Back to search results

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Autosomal Dominant Polycystic Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University Hospital Zurich, Division of Nephrology, Zurich, Canton of Zurich, Switzerland

    Contact: Study coordinator (Thomas Schachtner, MD)

  • Cantonal Hospital Graubuenden, Chur, Kanton Graubünden, Switzerland

    Contact: Study coordinator (Patrick Hofmann, MD) · medizin@ksgr.ch
    Lorena Roth, MD (Sub-investigator)
Study leads

  • Thomas Fehr, MD

    Principal Investigator

    Cantonal Hospital Graubuenden

  • Patrick Hofmann, MD

    Principal Investigator

    Cantonal Hospital Graubuenden

View source on ClinicalTrials.gov(opens in a new tab)